Nordic Stem Cell Clinic ApS: Financial statements 2024
CVR: 44048434
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Nordic Stem Cell Clinic ApS (CVR 44048434) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -264,713 and a net result of DKK -264,713. Equity in the 2024 report amounted to DKK 838,543. The solvency ratio was 19.2%.
- Gross Profit
- DKK -264,713
- Profit/Loss
- DKK -264,713
- Equity
- DKK 838,543
- Total Assets
- DKK 4,375,930
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Nordic Stem Cell Clinic ApS has published its interim report for the period May 9, 2023 to December 31, 2023.
On February 7, 2024, the company changed its name from Blue Cell Clinics ApS to Nordic Stem Cell Clinic ApS.
About Nordic Stem Cell Clinic ApS
Nordic Stem Cell Clinic ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Blue Cell Clinics ApS. The management consists of Søren Paludan Sheikh. The company is owned by ANDRÉ ROGACZEWSKI HOLDING II ApS, SPSheikh Holding ApS and Ulveman Invest ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -68,935 and a net result of DKK -4,310,487 compared with DKK -264,713 the year before. Equity in the 2025 report amounted to DKK -3,471,944.
